Pneumocystis jirovecii infection is a serious public health problem and can affect any part of the body (intestinal tract, skin, lungs, eyes, ears, kidneys, and urinary tract). The main indication for antimicrobial therapy is the treatment of bacterial pneumonia, which usually starts in the middle of the respiratory tract (pneumococcal pneumonia). It is also associated with increased risk of death in the long term. Therapy must be modified as required, depending on the nature of the infection and the severity of the patient. It is important to avoid all possible infections before therapy, even if the infection does not appear to be resistant to conventional antibiotics. Therefore, in patients with uncomplicated pneumonia, therapy is often combined with empiric antibiotics, which may lead to antibiotic resistance and a recurrence of the infection. In the context of antimicrobial therapy for bacterial pneumonia, several therapeutic strategies have been developed, including the use of non-antibiotic agents (such as ciprofloxacin, doxycycline, levofloxacin, and amoxicillin), which are also considered effective for the treatment of bacterial pneumonia, especially in high-risk patients. These agents include the following classes of antibiotics: ciprofloxacin, levofloxacin, amoxicillin, tetracycline, and doxycycline.
Pneumocystis jirovecii infection (PJI) is a serious public health problem and can affect any part of the body (intestinal tract, skin, lungs, eyes, ears, kidneys, and urinary tract). Therefore, in patients with uncomplicated PJI, therapy is often combined with empiric antibiotics, which may lead to antibiotic resistance and a recurrence of the infection.
The aim of this study was to assess the appropriateness of the use of ciprofloxacin, levofloxacin, amoxicillin, tetracycline, and doxycycline for PJI. A retrospective cohort study was conducted of all PJI patients with a history of PJI in the general practice in our hospital. The patients were randomly divided into three groups, based on the duration of the infection: (1) Group A; (2) Group B; and (3) Group C. Group A received ciprofloxacin, levofloxacin, amoxicillin, tetracycline, and doxycycline as a single treatment. Group B received amoxicillin, tetracycline, and doxycycline as a single treatment for a 7-day course of ciprofloxacin, levofloxacin, amoxicillin, and tetracycline as a single treatment for a 7-day course of amoxicillin and tetracycline as a single treatment for a 7-day course of levofloxacin, amoxicillin, and tetracycline as a single treatment for a 7-day course of amoxicillin and tetracycline as a single treatment for a 7-day course of doxycycline. The primary endpoints were the incidence of PJI and the recurrence of the infection. Statistical analyses were conducted using the IBM SPSS version 23 (IBM Corp, Armonk, NY). The data were presented as mean ± standard deviation (SD). The statistical significance of the difference between groups was determined using an independent-samples t-test and by the Mann-Whitney U test.
Treatment of bacterial infections of the ear, nose, and sinuses. Can be used at the following sites: - in the treatment of infections of the skin - in the treatment of infections of the skin (such as urinary tract infections, bronchitis, pneumonia) - in the treatment of infections of the skin (such as respiratory tract infections, infections of the skin (such as liver disease) - in the treatment of infections of the skin (such as kidney infections, bone, joint, muscle, and bone infection) - in the treatment of infections of the skin (such as skin infections, including cellulitis, impetigo, animal bites, cuts, or scratches) - in the treatment of infections of the skin (such as respiratory tract infections, infections of the skin (such as liver disease) - in the treatment of infections of the skin (such as kidney infections, bone infection) - in the treatment of infections of the skin (such as cellulitis, impetigo, animal bites, scratches) - in the treatment of infections of the skin (such as skin infections, including cellulitis, impetigo, animal bites, skinks) - in the treatment of respiratory tract infections - in the treatment of infections of the skin (such as urinary tract infections, bronchitis, pneumonia) - in the treatment of respiratory tract infections - in the treatment of infections of the skin (such as urinary tract infections, bronchitis, pneumonia) - in the treatment of infections of the skin (such as respiratory tract infections, bronchitis, pneumonia) - in the treatment of infections of the skin (such as respiratory tract infections) - in the treatment of respiratory tract infections - in the treatment of infections of the skin (such as urinary tract infections, bronchitis, pneumonia) - in the treatment of infections of the skin (such as respiratory tract infections, bronchitis, pneumonia) - in the treatment of infections of the skin (such as urinary tract infections, bronchitis, pneumonia)AdultsThe use of the drug Ciprofloxacin is contraindicated in patients with a known hypersensitivity to Ciprofloxacin or any other part of this drug. This product has been prescribed for use in combination with I. V. ophthalmic solutions for treatment of infections caused by urinary tract infections, bronchitis, pneumonia, bone and joint infections, perioral infections and other infections. - in case of accidental ingestion by a person, it is recommended to refrain from consuming Ciprofloxacin and to consult with your doctor or pharmacist if you experience any side effects or have experienced them with other antibiotic medications. The side effects of Ciprofloxacin are mild and may include nausea, vomiting, diarrhea, high blood pressure, heart failure, jaundice or liver damage. Patients with severe liver disease should avoid the administration of Ciprofloxacin and your doctor for the full duration of treatment with this drug. The patient should be observed for anylasting effects after discontinuing the medication. The use of Ciprofloxacin is contraindicated in patients with a known hypersensitivity to Ciprofloxacin or any other drug. This drug has been prescribed in patients with severe liver disease and a history of these diseases being treated with this drug. Ciprofloxacin has been shown to potentiate the hypotensive effects of nitrates and myocardial infarction in some patients. Therefore, Ciprofloxacin should not be used with nitrates or mIs prescribed for the treatment of angina. Ciprofloxacin should only be used in patients with a recent history of hypersensitivity to Ciprofloxacin or any other product or disease. Therefore, in patients with a recent history of hypersensitivity to any component of this product, Ciprofloxacin should be administered with caution and under the supervision of a doctor. The use of Ciprofloxacin is not recommended in patients with a history of gastrointestinal tract disease. In this case, the drug should be administered with caution and under the supervision of a doctor. In patients who have a history of gastrointestinal tract disease, Ciprofloxacin should be administered with caution and under the supervision of a doctor. The use of Ciprofloxacin is not recommended in patients with a history of gastrointestinal disease. In patients who have a history of cardiovascular disease, Ciprofloxacin should be administered with caution and under the supervision of a doctor. The use of Ciprofloxacin is not recommended in patients with a history of cardiovascular disease.
Pregnancy and lactation: The aim of this study is to evaluate the effects of a single dose of quinolones and ciprofloxacin on maternal and fetal health and on the neonatal outcome of birth to term. The effect of the quinolone on maternal and fetal health was evaluated in a prospective observational study with a large sample size and a relatively large sample size, in the period from 1st to 28th day after birth, using the Pediatric Data and Safety Monitoring Program (PSUV). It is known that quinolone use during pregnancy is associated with a low risk of major and minor congenital malformations. However, there are many questions about the effect of quinolones on maternal and fetal health, particularly for children. The aim of this study was to evaluate the effects of a single dose of ciprofloxacin and a single dose of quinolones on maternal and fetal health and on the neonatal outcome of birth to term.
ObjectiveTo evaluate the effects of single doses of ciprofloxacin and quinolones on maternal and fetal health. The population study was carried out in the neonatal intensive care units (NIU) of the Pediatric Specialty Unit at the University of Sintors in Sintors-Norries (US), in the Netherlands. The neonatal intensive care unit (NIU) provides all neonates with a comprehensive Neonatal Network and the neonatal intensive care units (NIU) are equipped with a variety of diagnostic, monitoring, and supportive equipment. The neonatal intensive care units are used to monitor the neonatal status of the newborn (NINU). The aim of this study is to evaluate the effects of single doses of ciprofloxacin and a single dose of quinolones on maternal and fetal health and on the neonatal outcome of birth to term.
$0.00
$0.00
Ciprofloxacin is used to treat a wide variety of bacterial infections, including those affecting the eyes, ear, sinuses, urinary tract, skin, and lungs. It belongs to a group of medicines called quinolone antibiotics. Ciprofloxacin works by stopping the growth of bacteria.
Read the Medication Guide provided by your pharmacist before you start taking ciprofloxacin and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
The usual starting dose for Ciprofloxacin is one tablet (500 mg) taken three times a day for seven days. The dosage depends on the infection being treated and the patient’s age, weight, medical history, and response to treatment. If the infection is sensitive to tablets, a lower dosage may be prescribed. Take the medicine orally, with or without food, with food particles (not sugar) in the mouth and throat. The throat may become soft or flaky, as with most drugs, the drug will not work if sugar has been released.
The course of treatment should be completed to ensure that the drug is fully absorbed and to prevent any secondary effects from the drug. Do not stop taking Ciprofloxacin or any drug for that matter without consulting your doctor.
The side effects of Ciprofloxacin can include nausea, vomiting, diarrhea, and jaundice. In rare cases, these side effects can also be serious. If any of these effects persist or worsen, contact your doctor immediately.
As with all medications, there may be a risk of a severe allergic reaction if you take Ciprofloxacin with food.
Ciprofloxacin may interact with other medications you are taking for infections.
Do not take Ciprofloxacin with any of the following medications:
Some examples:
The following are medications that may interact with Ciprofloxacin:
This page was updated:October 2025. This page was updated on October 26, 2025.
The following table lists the most commonly used Ciprofloxacin (Cipro) registered in Ireland with the company that manages them.
Some of the medicines in this table have been added by companies as follows:
Ciprofloxacin (Ciprofloxacin) is a medication used to treat certain types of infections caused by bacteria. Ciprofloxacin belongs to a group of antibiotics called fluoroquinolones, which work by stopping the growth of bacteria.
The following medicines have been added by companies as follows:
The following is a list of medicines that are considered a part of the Ciprofloxacin (Cipro) register:
Amoxicillin is a common antibiotic that can be used to treat a wide variety of infections caused by bacteria. Amoxicillin works by stopping the bacteria from growing and multiplying, which can help to prevent the infection from developing further.
Ciprofloxacin (Cipro) is a medicine used to treat certain types of infections caused by bacteria.
Ciprofloxacin (Cipro) belongs to a group of antibiotics called fluoroquinolones, which work by stopping the growth of bacteria. Fluoroquinolones belong to a class of antibiotics called quinolone antibiotics, which are effective against infections caused by bacteria. Ciprofloxacin works by stopping the growth of bacteria in the body and helps to kill them.
Ciprofloxacin (Cipro) is an antibiotic used to treat a wide range of infections caused by bacteria.
Stade de France Pharmacy